WO2002031111A3 - Novel nucleic acids and polypeptides - Google Patents
Novel nucleic acids and polypeptides Download PDFInfo
- Publication number
- WO2002031111A3 WO2002031111A3 PCT/US2001/027760 US0127760W WO0231111A3 WO 2002031111 A3 WO2002031111 A3 WO 2002031111A3 US 0127760 W US0127760 W US 0127760W WO 0231111 A3 WO0231111 A3 WO 0231111A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acids
- polypeptides
- novel nucleic
- novel
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002425827A CA2425827A1 (en) | 2000-10-12 | 2001-10-11 | Novel nucleic acids and polypeptides |
EP01977088A EP1325120A4 (en) | 2000-10-12 | 2001-10-11 | Novel nucleic acids and polypeptides |
AU2001296235A AU2001296235A1 (en) | 2000-10-12 | 2001-10-11 | Novel nucleic acids and polypeptides |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68752700A | 2000-10-12 | 2000-10-12 | |
US09/687,527 | 2000-10-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002031111A2 WO2002031111A2 (en) | 2002-04-18 |
WO2002031111A3 true WO2002031111A3 (en) | 2002-10-17 |
Family
ID=24760764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/027760 WO2002031111A2 (en) | 2000-10-12 | 2001-10-11 | Novel nucleic acids and polypeptides |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1325120A4 (en) |
AU (1) | AU2001296235A1 (en) |
CA (1) | CA2425827A1 (en) |
WO (1) | WO2002031111A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6774223B2 (en) | 2000-06-28 | 2004-08-10 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1074617A3 (en) * | 1999-07-29 | 2004-04-21 | Research Association for Biotechnology | Primers for synthesising full-length cDNA and their use |
WO2001034636A1 (en) * | 1999-11-05 | 2001-05-17 | The General Hospital Corporation | Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
US8642284B1 (en) | 1999-12-15 | 2014-02-04 | Massachusetts Institute Of Technology | Methods for identifying agents that alter NAD-dependent deacetylation activity of a SIR2 protein |
US7452664B2 (en) | 1999-12-15 | 2008-11-18 | Massachusetts Institute Of Technology | Methods for identifying agents which alter histone protein acetylation |
US7510855B2 (en) | 2000-01-26 | 2009-03-31 | Agensys, Inc. | 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer |
JP2002034565A (en) * | 2000-07-19 | 2002-02-05 | Japan Science & Technology Corp | Receptor protein specifically recognizing bacterial dna |
WO2002030963A1 (en) * | 2000-10-12 | 2002-04-18 | Exelixis, Inc. | Human ect2 and methods of use |
US20060127890A1 (en) * | 2000-10-30 | 2006-06-15 | Nobuyuki Koyama | Novel gene overexpressed in heart and skeletal muscle and use thereof |
US7572575B2 (en) | 2000-12-13 | 2009-08-11 | Massachusetts Institute Of Technology | SIR2 activity |
MXPA03005436A (en) | 2000-12-20 | 2004-05-05 | Bristol Myers Squibb Co | Polynucleotides encoding novel human phosphatases. |
EP1383797A2 (en) * | 2001-02-07 | 2004-01-28 | Universiteit Maastricht | Markers of unstable atherosclerotic plaques |
DE60230051D1 (en) * | 2001-04-10 | 2009-01-08 | Agensys Inc | NUCLEIC ACID AND CORRESPONDING PROTEIN NAMELY 121P2A3 FOR THE TREATMENT AND DETECTION OF CANCER |
WO2002098356A2 (en) * | 2001-06-05 | 2002-12-12 | Exelixis Inc. | Ppp2cs as modifiers of the p53 pathway and methods of use |
WO2003004989A2 (en) | 2001-06-21 | 2003-01-16 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
JP2003024080A (en) * | 2001-07-19 | 2003-01-28 | Univ Tokyo | Protein inducing p53-dependent apoptosis and method for screening apoptosis controlling agent |
WO2004005512A1 (en) * | 2002-07-09 | 2004-01-15 | Takeda Pharmaceutical Company Limited | Nove protein and use thereof |
JP4301541B2 (en) * | 2002-09-05 | 2009-07-22 | 独立行政法人科学技術振興機構 | Screening method of SMG-1 binding protein and substance controlling its activity |
US20060199181A1 (en) * | 2002-09-11 | 2006-09-07 | Genentch, Inc. | Compositions and methods for the treatment of immune related diseases |
AU2003279322A1 (en) * | 2002-11-08 | 2004-06-07 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a3 (pde11a3) |
AU2003901055A0 (en) * | 2003-02-17 | 2003-03-20 | Nathan E Hall | Methods for inhibiting signal transduction |
JP2006525031A (en) * | 2003-05-07 | 2006-11-09 | ユニバーシティー オブ マサチューセッツ | Method for controlling Acheron expression |
WO2004112575A2 (en) * | 2003-06-20 | 2004-12-29 | Amgen Inc. | Gene amplification and overexpression in cancer |
WO2005014817A2 (en) * | 2003-08-07 | 2005-02-17 | Compugen Ltd. | Chordin-like homologs |
JP2008502307A (en) * | 2003-10-28 | 2008-01-31 | プロテミックス ディスカバリー リミティド | Peptides with anti-obesity activity and other related uses |
KR100878959B1 (en) | 2004-02-09 | 2009-01-19 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | Screening method |
US20080199468A1 (en) * | 2004-02-24 | 2008-08-21 | Oncotherapy Science, Inc. | Method For Diagnosing Colorectal Cancers |
EP2169060B1 (en) * | 2004-06-02 | 2011-12-07 | TSS Biotech Inc. | Novel polypeptide useful for diagnosis and treatment of cancer |
AU2005277508B2 (en) | 2004-08-16 | 2011-04-14 | Quark Pharmaceuticals, Inc | Therapeutic uses of inhibitors of RTP801 |
US7531634B2 (en) * | 2004-12-03 | 2009-05-12 | University Of Pittsburgh | Bladder matrix protein peptides and methods of detection of bladder cancer |
EP1856278A2 (en) * | 2005-02-10 | 2007-11-21 | Oncotherapy Science, Inc. | Method of diagnosing bladder cancer |
US20070099830A1 (en) | 2005-04-21 | 2007-05-03 | Massachusetts Institute Of Technology | Sirt4 activities |
WO2006115295A1 (en) * | 2005-04-25 | 2006-11-02 | University Of Yamanashi | Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction |
NL2000439C2 (en) | 2006-01-20 | 2009-03-16 | Quark Biotech | Therapeutic applications of inhibitors of RTP801. |
US7723052B2 (en) | 2006-05-11 | 2010-05-25 | Quark Pharmaceuticals, Inc. | Screening systems utilizing RTP801 |
EP2026843A4 (en) | 2006-06-09 | 2011-06-22 | Quark Pharmaceuticals Inc | Therapeutic uses of inhibitors of rtp801l |
KR101454287B1 (en) | 2006-10-17 | 2014-11-04 | 온코세라피 사이언스 가부시키가이샤 | Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
WO2008106102A2 (en) | 2007-02-26 | 2008-09-04 | Quark Pharmaceuticals, Inc. | Inhibitors of rtp801 and their use in disease treatment |
US8614311B2 (en) | 2007-12-12 | 2013-12-24 | Quark Pharmaceuticals, Inc. | RTP801L siRNA compounds and methods of use thereof |
JP2011529501A (en) * | 2008-07-28 | 2011-12-08 | イデラ ファーマシューティカルズ インコーポレイテッド | Regulation of Toll-like receptor 9 expression by antisense oligonucleotides |
US8975086B2 (en) | 2008-08-28 | 2015-03-10 | Oncotherapy Science, Inc. | Method for treating or preventing bladder cancer using the DEPDC1 polypeptide |
CN102356155B (en) | 2009-03-18 | 2016-02-24 | 肿瘤疗法科学股份有限公司 | NEIL3 peptide and comprise its vaccine |
US8815779B2 (en) | 2009-09-16 | 2014-08-26 | SwitchGear Genomics, Inc. | Transcription biomarkers of biological responses and methods |
GB201009654D0 (en) * | 2010-06-09 | 2010-07-21 | Cancer Res Technology | Nucleic acid methyltransferase |
TWI467016B (en) * | 2011-08-31 | 2015-01-01 | Taipei Veteran General Hospital | Gene delivery of oct4 and sirt1 and pharmaceutical compositions thereof |
US10653782B2 (en) * | 2014-11-25 | 2020-05-19 | Nortwestern University | Retroviral particles expressing Sirt1 embedded within PPCN |
JP6934250B2 (en) | 2015-08-12 | 2021-09-15 | オンコセラピー・サイエンス株式会社 | DEPDC1-derived peptide and vaccine containing it |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2383800A1 (en) * | 1999-09-03 | 2001-03-15 | Human Genome Sciences Inc. | 52 human secreted proteins |
EP2267026A1 (en) * | 2000-04-12 | 2010-12-29 | Human Genome Sciences, Inc. | Albumin fusion proteins |
-
2001
- 2001-10-11 AU AU2001296235A patent/AU2001296235A1/en not_active Abandoned
- 2001-10-11 EP EP01977088A patent/EP1325120A4/en not_active Withdrawn
- 2001-10-11 CA CA002425827A patent/CA2425827A1/en not_active Abandoned
- 2001-10-11 WO PCT/US2001/027760 patent/WO2002031111A2/en not_active Application Discontinuation
Non-Patent Citations (2)
Title |
---|
"Random primers DNA labeling system", GIBCO BRL CATALOGUE AND REFERENCE GUIDE, LIFE TECHNOLOGIES, INC., 1990, GAITHERSBURG, MD 20877, USA, pages 404, XP002950899 * |
See also references of EP1325120A4 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6774223B2 (en) | 2000-06-28 | 2004-08-10 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
Also Published As
Publication number | Publication date |
---|---|
AU2001296235A1 (en) | 2002-04-22 |
WO2002031111A2 (en) | 2002-04-18 |
EP1325120A2 (en) | 2003-07-09 |
CA2425827A1 (en) | 2002-04-18 |
EP1325120A4 (en) | 2005-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001075067A3 (en) | Novel nucleic acids and polypeptides | |
WO2001057188A3 (en) | Novel nucleic acids and polypeptides | |
WO2001057190A3 (en) | Novel nucleic acids and polypeptides | |
WO2002022660A3 (en) | Novel nucleic acids and polypeptides | |
WO2001066689A3 (en) | Novel nucleic acids and polypeptides | |
WO2002031111A3 (en) | Novel nucleic acids and polypeptides | |
WO2001088088A3 (en) | Novel nucleic acids and polypeptides | |
WO2002059260A3 (en) | Nucleic acids and polypeptides | |
WO2003054152A3 (en) | Novel nucleic acids and polypeptides | |
WO2003025148A3 (en) | Novel nucleic acids and polypeptides | |
WO2002070539A3 (en) | Novel nucleic acids and polypeptides | |
WO2003023013A3 (en) | Novel nucleic acids and polypeptides | |
WO2002081731A3 (en) | Novel nucleic acids and polypeptides | |
WO2001053312A8 (en) | Novel nucleic acids and polypeptides | |
WO2001053455A3 (en) | Novel nucleic acids and polypeptides | |
WO2004009834A3 (en) | Novel nucleic acids and secreted polypeptides | |
WO2003029271A3 (en) | Novel nucleic acids and polypeptides | |
WO2004080148A3 (en) | Novel nucleic acids and polypeptides | |
WO2002018424A3 (en) | Nucleic acids and polypeptides | |
WO2004087874A3 (en) | Novel nucleic acids and polypeptides | |
WO2001079449A3 (en) | Novel nucleic acids and polypeptides | |
WO2001002571A3 (en) | An interleukin-1 receptor antagonist and uses thereof | |
WO2003080795A8 (en) | Novel nucleic acids and secreted polypeptides | |
WO2001075068A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO2002044340A3 (en) | Novel nucleic acids and polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2425827 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001977088 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001977088 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001977088 Country of ref document: EP |